Literature DB >> 278178

Pharmacokinetic studies on diclofenac sodium in young and old volunteers.

J V Willis, M J Kendall.   

Abstract

A singel 50 mg enteric-coated tablet of diclofenac sodium (Voltaren) was administered to two groups, each consisting of eight female subjects. The subjects in the one group were young adults all aged less than 22 years, while those in the other were all over the age of 62 years. The plasma concentration/time profiles, relative bio-availability, and urinary excretion pattern of the drug in the two groups were similar. Thus, in the absence of interacting factors, such as drugs and disease, the ability to absorb, metabolise, and excrete diclofenac sodium does not appear to be influenced by age.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 278178     DOI: 10.3109/03009747809097214

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  16 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies.

Authors:  Nils Helge Schebb; Bora Inceoglu; Tristan Rose; Karen Wagner; Bruce D Hammock
Journal:  Anal Methods       Date:  2011-01-01       Impact factor: 2.896

Review 3.  Switching drug availability from prescription only to over-the-counter status. Are elderly patients at increased risk?

Authors:  S I Benrimoj; J H Langford; M G Bowden; E J Triggs
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

4.  Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.

Authors:  A Karim
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers.

Authors:  X Hui; P G Hewitt; N Poblete; H I Maibach; J Z Shainhouse; R C Wester
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 6.  Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury.

Authors:  B H McCarberg; C E Argoff
Journal:  Int J Clin Pract       Date:  2010-10       Impact factor: 2.503

Review 7.  Non-steroidal anti-inflammatory analgesics other than salicylates.

Authors:  R N Brogden
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 8.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 9.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  The pharmacokinetics of diclofenac sodium following intravenous and oral administration.

Authors:  J V Willis; M J Kendall; R M Flinn; D P Thornhill; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.